Tag Archives: HEA

PR Newswire

Launch of #SGUnited COVID-19 Assistance Telemedicine Initiative by UNO Tech

Leave a comment

SINGAPORE, Oct. 27, 2021 — Singapore has seen a sharp increase in daily COVID-19 cases since September, reaching an approximate average of 3,000 daily cases. Primary Care avenues such as General Practitioners and Telemedicine service providers are stretched thin.

UNO Technologies launches COVID-19 Assistance Telemedicine Initiative
UNO Technologies launches COVID-19 Assistance Telemedicine Initiative

UNO Technologies (https://www.unotech.io/uno-docket-covid19-assistance/) has mobilized its resources to modify its solution and deployed a telemedicine solution addressing COVID-19 related issues. This aims to help alleviate the anxiety and uncertainty that many Singapore residents are facing related to the pandemic, by providing them an avenue to reach out to Doctors for advice. Moreover, reducing the odds of community spread by reducing physical visits and re-directing non-critical cases away from primary care facilities, reducing the strain.

UNO Technologies’ parent company Essex Bio-Technology Ltd has also committed SGD $250,000 in funding to help sponsor all qualifying first consults on our COVID-19 Telemedicine platform. This seeks to remove any financial barriers for patients needing advice on what to do next with their exposure to this pandemic.

All Doctors on this initiative are Singapore Medical Council registered practitioners. As of 27 Oct 2021 there are more than 20 Doctors on board and the team is working hard to onboard more to meet the demands of this initiative.

Who are eligible?

  • Not covered by MOH’s Home Recovery Programme Telemedicine Providers
  • Not serving Isolation Order

How does this work?

  • Search and download ‘UNO Docket’ on iOS App Store (Android version coming soon)
  • Register for an account
  • Complete the COVID-19 Triage questions
  • Select an available GP Clinic in your neighbourhood
  • Qualifying first-consults on our platform are free, no payment required

To download the UNO Docket COVID-19 Assistance Telemedicine App, click this link https://apps.apple.com/sg/app/docket/id1522234869 or search for the UNO Docket on IOS App Store.

Doctors needed

  • This initiative is calling for Doctors to come onboard and join the cause.
  • If interested, please email hello@unotech.io.

UNO Technologies is a Med-Tech company aiming to help medical practitioners improve the efficiency and quality of care for their patients by leveraging on the latest technologies. Our solutions have impacted over 1,000,000 patients and 2,000 practitioners to date. UNO Technologies is also a proud partner of IHIS’s SmartCMS Programme.

 

Related Links :

https://www.unotech.io

PR Newswire

Artificial Intelligence to Boost the Global Wound Care Market by 2026 with Minimal Intervention Solutions

Leave a comment

The global wound care solutions market is estimated to garner $30.5 billion in revenue by 2026 at a compound annual growth rate of 6.7%, finds Frost & Sullivan

SAN ANTONIO, Oct. 18, 2021 — Frost & Sullivan’s recent analysis, Global Wound Care Solutions and New-age Technology Growth Opportunities, finds that participants in the wound care industry are investing heavily in technologies and solutions that require minimal/no medical intervention and can be used by patients, family and care providers. Primarily contributed by basic and advanced wound care solutions product types, the global wound care solutions market is estimated to garner $30.5 billion in revenue by 2026 from $20 billion in 2020, an uptick at a compound annual growth rate (CAGR) of 6.7%.

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”
 

jwplayer(‘myplayer1’).setup({file: ‘https://www.youtube.com/watch?v=AVVcwLr30F0’, image: ‘http://www.prnasia.com/video_capture/3541808_AE41808_1.jpg’, autostart:’false’, aspectratio: ’16:9′, stretching : ‘fill’, width: ‘600’, height: ‘338’});

With technological advancements and a diverse array of traditional and advanced wound care solutions comprising apps, software, services, devices, and wearables, North America will dominate the wound care market by 2026. Also, the European wound care market will witness stable growth as the market becomes saturated due to technological advancements. Asia-Pacific will see a maximum growth rate as countries across the region adopt wound care solutions rapidly. Similarly, a surge in demand for faster wound recovery and advanced wound dressings in the Middle East and Latin America, respectively, will drive the wound care solutions market in the rest of the world over the forecast period.

For further information on this analysis, please visit: https://frost.ly/6eh

"The requirement for faster, less-invasive wound healing is boosting the demand for advanced wound care solutions," said Suchismita Das, Healthcare & Life Sciences Research Analyst at Frost & Sullivan. "Additionally, the resumption of elective surgeries that were placed on hold during the pandemic will further boost the post-pandemic demand for surgical wound care solutions."

Das added: "As end-users increasingly prefer ‘at-home’ solutions, simple and effective wound monitoring devices and solutions that require less intervention from clinicians are gaining traction. Further, the artificial intelligence (AI)-enabled solutions, sensor-based devices/wearables, and wound assessment devices aid care providers with clinical decision support (CDS) for faster diagnosis of complex wounds, leading to effective care pathways."

Government and corporate funding for developing next-gen wound care solutions that primarily enable early wound detection and prevention is set to increase, presenting the following growth opportunities for market participants:  

  • Increased government recommendations for preventive solutions: The need to address the current and future threats of microbial infections and healthcare-acquired pressure injuries (HAPI) will benefit healthcare information technology (HIT) companies. They must invest in developing technologically advanced solutions.
  • AI-enabled wound care solutions for faster and accurate diagnosis: HIT companies can leverage AI for innovative, next-gen solutions through partnerships or mergers and acquisitions.
  • Flexible smart bandage with embedded sensors to enable real-time data on healing and medicine delivery: Vendors can partner with or acquire start-ups actively researching and developing such solutions. 
  • The use of chitosan can be a game-changer in the wound-healing space: Market participants must broaden their chitosan-based wound care product portfolio because of its quick-healing features for all wound types.

Global Wound Care Solutions and New-age Technology Growth Opportunities is the latest addition to Frost & Sullivan’s Healthcare & Life Sciences research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Global Wound Care Solutions and New-age Technology Growth Opportunities
MG30

Contact:
Mariana Fernandez
Corporate Communications
E: Mariana.Fernandez@frost.com
http://ww2.frost.com

 

Related Links :

Frost New Home page v2

PR Newswire

UPL Announces Long-term Collaboration With Chr. Hansen To Develop And Commercialize Microbial Solutions For Sustainable Agriculture

Leave a comment

– UPL is the largest manufacturer and distributor of biosolutions worldwide, fifth-largest agribusiness globally.

– Chr. Hansen is the owner of one of the world’s largest commercial collections of bacteria, with more than 28,000 strains

– The biosolutions market set to grow to $10bn* USD by 2025 as consumers demand more sustainable food systems

MUMBAI, India, Oct. 16, 2021 — UPL Ltd. (‘UPL’) (NSE: UPL) (BSE: 512070), a world-leading champion of sustainable agriculture and OpenAg™, has announced a long-term strategic collaboration with Chr. Hansen, a global bioscience company, to develop microbial-based biosolutions (including biostimulants and biopesticides) that will help growers around the world fight pests and diseases, and improve crop quality and yields.

Through this collaboration, UPL will use its global presence to undertake research and identify opportunities and product concepts to address farmers’ pain points. From these insights, Chr. Hansen will design biological products based on their microbial capabilities and UPL will register and commercialize these products via its extensive global distribution network.

UPL is the world’s largest manufacturer and distributor of biosolutions, and earlier this year launched ‘NPP – Natural Plant Protection’ – a new global business unit  championing UPL’s comprehensive portfolio of natural and biologically derived agricultural inputs and technologies.

Vicente Gongora, Chief Marketing Officer at UPL Ltd. said:

"Biosolutions are a core pillar of our global purpose and work to reimagine sustainability – for food systems, for farmers, and for our environment. Building on the launch of NPP earlier in the year, we are proud to partner with Chr. Hansen to further expand our portfolio of products and technologies – and to offer new and sustainable solutions for more farming communities. 

"Consolidating our distribution networks and R&D facilities alongside Chr. Hansen’s unique microbial experience and expertise presents a powerful opportunity to change the game for farmers and for sustainable agriculture globally. We look forward to sharing more news on the biological solutions that we are developing for the future, and we are excited about the legacy we will build together."

Kim Christensen, Vice President of Plant Health at Chr. Hansen said:

"UPL is a significant distributor of biosolutions worldwide. Combining that with Chr. Hansen’s significant innovations in research and development, as well as our unique microbial capabilities and ability to breed our own bacteria, will mean better, targeted products that can go to market faster. The partnership is an important step in our 2025 strategy of growing a better world naturally. In essence, the collaboration aims to establish a product pipeline that has the best interests of farmers at heart."

The UPL-Chr. Hansen partnership has already identified several projects relevant to farmers globally and aims to develop a product pipeline for all major crops that will enable farmers to fight crop diseases and increase their yields. The companies are expecting the first registrations to start coming by the end of 2022.

* Value for Biocontrol & BioStimulants Market

 

 

PR Newswire

Neusoft Ranks Top in China Healthcare Security Informatization Market

Leave a comment

SHENYANG, China, Oct. 15, 2021 — According to the Market Shares of Healthcare Security Information System of China 2020: Building a New Healthcare Security Information System recently released by International Data Corporation (IDC) for the first time, Neusoft Corporation ("Neusoft", SSE: 600718) ranks the top in the healthcare security information system market of China based on its comprehensive advantages such as deep understanding of the healthcare security industry, stable products and mature industry ecology.

Neusoft has devoted to developing and promoting healthcare security information systems since 1994, and has continuously innovated the systems along with the reform of healthcare security and medicine & healthcare in China for more than 20 years. Neusoft provides the complete series of healthcare security informatization solutions, including the core handling system of healthcare security, healthcare security public service, fund supervision and decision-making, big data governance and service, and improvement of informatization capability of designated medical institutions, so as to support the healthcare security management authorities to improve the healthcare security services.

As of September 2021, Neusoft has participated in the construction of the national and 23 provincial healthcare security information platforms, including the core handling systems of healthcare security in 9 provinces, established healthcare security information systems in more than 200 cities included in the national healthcare security arrangement, and successively launched the provincial systems online in Qinghai, Hainan, Hebei, Gansu, etc..

In the future, Neusoft will, based on the integration of the healthcare security, medical care, pharmaceutical solutions, leverage the internal and external resources in medical equipment, commercial insurance, health management, medical operation, scientific research and education to build a more complete new healthcare ecology, continuously innovate and improve the healthcare security information systems to meet the future demands, and lead the development of healthcare security informatization in China.

Related Links :

http://www.neusoft.com/en

PR Newswire

Posture360 Receives Venture Capital to Drive Growth in Healthcare Industry

Leave a comment

Industry Leader in Smart Wearables Taps Venture Capital For Strategic Growth

NEW YORK, Oct. 14, 2021 — Posture360, an industry leader in smart wearable technologies, has received an investment from Legendary Ventures as it is set to launch PostureSense®, the next-generation Smart Shirt that tracks, monitors, and analyzes physical activities (with real-time bio-feedback) through its SaaS platform to improve people’s posture. The PostureSense® Smart Shirt helps individuals develop better posture habits through its embedded fabric AI sensors (which collects behavioral data when worn), enabling people to change their posture, and correct for any misalignment on-the-fly.

Today, backpain adds a substantial socio-economic burden to millions of people everywhere. "Incredibly, backpain is the most common symptom that people suffer from in their daily lives. Our all-in-one digital health platform seamlessly integrates into our daily activities in non-evasive ways to boost overall health and wellness," says William Choi, Founder & CEO of Posture360.

Studies have shown that backpain is the leading cause of disability (and poor performance) worldwide, especially for young working professionals. "The need for a dynamic posture-correcting system has become essential as businesses and consumers shift towards a more passive aggressive post-pandemic work-life balance," says Ryan Shuler, Managing Partner of Legendary Ventures.

Legendary Ventures is a US-based venture capital firm that fuels consumer, retail, and technology ("CRT") companies. Other notable investors in Posture360 include Samsung Ventures, C&V Partners and nTels Ventures. "We’re very excited to support Posture360 deliver disruptive consumer MedTech products across the next-generation of lifestyle industries such as eGaming and eSports," says Jayson Kim, General Partner of Legendary Ventures.

About Posture360

Posture360 is a smart wearable company that provides effective interventions for pain management worldwide. Its ergonomic products are embedded with sensors to track, monitor, and analyze daily movements to improve health and wellness. For more information about the company, or its products, please visit www.posture360.com.

About Legendary Ventures

Legendary Ventures is a venture capital partnership that accelerates value creation for emerging companies operating across the CRT markets. For more information about the firm, or its funds, please visit www.legendary.vc.

Contact:

Public Relations
Anoushka Gungadin
Posture 360 Public Relations
pr@posture360.com

Investor Relations
Rachel Wu
Legendary Investor Relations
investors@legendary.vc

Related Links :

https://posture360.com/

PR Newswire

New Accedian Research Finds 76% of Manufacturers Plan to Use Private 5G by 2024

Leave a comment

Despite overwhelming inclination, barriers to 5G adoption remain, including high cost, deployment difficulty and management complexity

MONTREAL, Canada, Sept. 29, 2021 — Accedian, a leader in performance analytics, cybersecurity threat detection and end user experience solutions, today released new analyst research on the future of 5G in manufacturing. Conducted in partnership with Analysys Mason, a leading management consultancy focused on telecoms, media and technology (TMT), the research found that while 76% of manufacturers plan to use private 5G locally by 2024, key barriers to adoption include management complexity, difficulty of deployment and high costs. 

Manufacturing holds extreme promise in being transformed through 5G network adoption. As a sector largely reliant on the quality of connections between technologies and machines, 5G can expedite processes, reduce latency, enable automation and the adoption of artificial intelligence (AI), robotics and augmented reality (AR). Most manufacturers agree that high reliability (82%), security (78%) and support for low-latency applications (75%) make a 5G private network an attractive choice. 

"5G is set to transform industries, and no sector is more ripe for this than manufacturing," says Sergio Bea, VP of Global Enterprise and Channels, Accedian. "Our research with Analysys Mason clearly shows the appetite for adoption among manufacturers is there, but network performance monitoring and management remain barriers to entry. With the right network monitoring tools, IT teams at factories can be sure they’ll have both the visibility and security they need to make 5G adoption a success."

More than 200 respondents from Germany, Japan, the United Kingdom, and the United States across six verticals provided insights into private 5G network adoption. 

Key highlights from the research include:

  • The most likely types of 5G deployments are: hybrid models (45%) and network slice (35%); while 18% of manufacturing respondents prefer fully private on-prem networks.
  • Security (63%) is the biggest factor influencing the choice of 5G deployment model, followed by network performance (49%), speed/simplicity of deployment (49%), application performance (45%) and data privacy (43%).
  • In terms of barriers to adoption, respondents considering a hybrid network model are most concerned about management complexity (43%).
  • Most agree that important metrics to monitor are application performance KPIs (61%), closely followed by network performance KPIs (59%) and security KPIs (55%).     

There is a complex balance of risks and deployment choices that manufacturers will need to make as they move forward with 5G.

"Our research shows there is appetite for 5G in the manufacturing industry, which means there’s also immense opportunity for service providers to uplevel their relationships with factories, as well," says Michele Mackenzie, Principal Analyst, IoT and private networks, Analysys Mason. "CSPs need to capitalize on this momentum to become more than just vendors, but strategic partners to manufacturing organizations looking to navigate the future of the sector."

To download the complete research click here.

To learn more about Accedian’s Skylight™ platform visit: https://accedian.com/platform/skylight/.

Resources

Infographic: Industry 4.0: Manufacturing Private 5G Networks State of Play

Analyst Research: Accelerating Smart Manufacturing with Private 5G Networks

Webinar: Mobile Europe: Driving SmartX World with Private 5G Networks with Colt

Related Press Release: 5G-ENCODE: Accedian partners to support UK manufacturing innovation

Whitepaper: 5G Brief: The Manufacturing Opportunity

CONTACT:

Pragya Goel

SourceCode Communications
accedian@sourcecodecomms.com 
(203) 554 – 5820

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/accedian/r/new-accedian-research-finds-76–of-manufacturers-plan-to-use-private-5g-by-2024,c3423826

PR Newswire

Strategic Investment in proteanTecs from Industry Leaders MediaTek and Advantest Joined by Porsche Automobil Holding SE to Advance Electronics Health Monitoring

Leave a comment

Validates need for multi-segment visibility from production to system operation

HAIFA, Israel, Sept. 24, 2021 — proteanTecs, a global leader in deep data solutions for advanced electronics, announced today a $50 million extension to their Growth Equity Round, demonstrating accelerated market adoption of system health and performance monitoring across multiple verticals. The round extension was led by Koch Disruptive Technologies (KDT) and joined by strategic investors MediaTek and Advantest, together with Porsche SE, the major shareholder of Volkswagen Group, and Allied Group subsidiary Champion Motors, as well as current investors. This brings the company’s total funding to $150 million.

 

Based on deep data derived from Universal Chip Telemetry™ (UCT), proteanTecs provides cloud and edge enterprise SW solutions for electronics’ health and performance monitoring. Addressing end-to-end needs of mission-critical markets, the company serves some of the largest and most technologically innovative companies in Datacenter, Automotive and Communications.

proteanTecs onboards leading investors from multiple verticals
proteanTecs onboards leading investors from multiple verticals

The strategic investment reinforces the growing need for full lifecycle visibility, spanning all segments of the electronics industry. Eli Groner, managing director at KDT, commented: "Since KDT’s first investment in proteanTecs we’ve seen their continued success in scaling and developing their technology, and this new investment is a testament to our confidence in the company. The addition of leading strategic partners across multiple verticals will enable proteanTecs to continue to stay ahead of the curve in the exciting new world of real time electronics monitoring."

One of the main forces driving the paradigm shift to an integrative approach is the automotive industry, which is entering the next phase of its electrification, driven by rising customer demands for safety and connectivity.

Lutz Meschke, member of the board of management responsible for investment management at Porsche SE, said: "Due to the fast-paced technological advancements and the ever-growing requirements for new chip generations, we see an enormous market potential for proteanTecs’ technology leveraging predictive reliability, performance and power management. We see clear benefits and the necessity for the use of this technology across a wide range of industries including the automotive industry." 

Spurred by the progress of the digital revolution, and driven by complexities in design and manufacturing, advanced analytics are also transforming the way production testing is performed. Advantest, a leading manufacturer of automatic test equipment, is strategically reinforcing its core business by integrating traditional silos across the product lifecycle through cloud-based data.

"We are excited to add proteanTecs to our investment portfolio, and to welcome their collaboration in the Advantest Cloud Solutions’ open solution ecosystem", said Doug Lefever, president and CEO of Advantest America.  "The way we are addressing test today has changed. We are strategically transitioning to an integrated methodology, leveraging cloud and edge analytics based on multiple data sources. We look forward to working with proteanTecs on the next phase of semiconductor test, finding innovative and scalable ways to shape the future of test platforms."

Versatile deployment of advanced electronics is another key dynamic driving collaboration. MediaTek, a global semiconductor leader, enjoyed first mover advantage in AI and 5G, providing chipsets for smart home, connectivity, IoT and wearable, ASIC and smart mobile devices.

"The investment in proteanTecs aligns with our commitment to bring cross-platform technologies that help connect users to the world around them", said Brian Hsu, Managing Partner of MediaTek Capital. "Robust, high-efficiency and low-power-consumption ICs are key to driving a scalable digital future. We believe synergies from strong technology portfolios and proteanTecs’ predictive performance capabilities will grow product value and enable unique competitive advantages."

The addition of strategic investors comes on the heels of a momentous year for proteanTecs. In 2020-2021, the company onboarded key customers, including cloud hyperscalers, leading system OEMs, disruptive fabless startups, and ASIC houses, enabling the formation of a value-add solution portfolio. The extended financing will be used to fuel global expansion, accelerate product development, and pursue strategic collaborations.

"The investment will strengthen proteanTecs’ technological and market leadership", said Shai Cohen, CEO and co-founder of proteanTecs. "It solidifies our strategy of bringing together market leaders’ diverse view points to solve a cross-stake challenge, while validating the need for advanced monitoring solutions from design to field. We’re grateful for the existing and new investors’ support and shared vision to bring a common data language to the industry."

About Porsche SE

Porsche Automobil Holding SE ("Porsche SE") is a listed investment company and a major shareholder of Volkswagen AG, in which Porsche SE holds 53.3 percent of ordinary shares and 31.4 percent of capital. In addition to the core holding in Volkswagen AG, Porsche SE is a global investor in the mobility and industrial technology sectors. Porsche SE focuses on high-quality growth companies that thrive on strong macro trends and are led by excellent management teams.

About Advantest Corporation

Advantest (TSE: 6857) is the leading manufacturer of automatic test and measurement equipment used in the design and production of semiconductors for applications including 5G communications, the Internet of Things (IoT), autonomous vehicles, artificial intelligence (AI), machine learning, smart medical devices and more.  Its leading-edge systems and products are integrated into the most advanced semiconductor production lines in the world.  The company also conducts R&D to address emerging testing challenges and applications, produces multi-vision metrology scanning electron microscopes essential to photomask manufacturing, and offers groundbreaking 3D imaging and analysis tools.  Founded in Tokyo in 1954, Advantest is a global company with facilities around the world and an international commitment to sustainable practices and social responsibility.  More information is available at www.advantest.com.

About MediaTek Inc.

MediaTek Incorporated (TWSE: 2454) is a global fabless semiconductor company that enables nearly 2 billion connected devices a year. We are a market leader in developing innovative systems-on-chip (SoC) for mobile device, home entertainment, connectivity and IoT products. Our dedication to innovation has positioned us as a driving market force in several key technology areas, including highly power-efficient mobile technologies, automotive solutions and a broad range of advanced multimedia products such as smartphones, tablets, digital televisions, 5G, Voice Assistant Devices (VAD) and wearables. MediaTek empowers and inspires people to expand their horizons and achieve their goals through smart technology, more easily and efficiently than ever before. We work with the brands you love to make great technology accessible to everyone, and it drives everything we do. Visit www.mediatek.com for more information.

About KDT

Koch Disruptive Technologies (KDT) is a unique investment firm, focused on empowering founders to create a could-be world. KDT provides a flexible, multi-stage investment approach which includes both traditional venture and growth stages. We work with principled entrepreneurs who are building transformative companies, disrupting the status quo, and creating new platforms. KDT is a subsidiary of Koch Industries, one of the largest privately held companies in the world with $110 billion in revenue and operating in more than 70 countries. KDT helps its partners unlock their full potential by bringing Koch’s capabilities and network to them, structuring unique capital solutions, and embracing a long-term, mutual benefit mindset.

About proteanTecs

proteanTecs develops revolutionary Universal Chip Telemetry™ (UCT) for electronic systems throughout their entire lifecycle, increasing their performance and reliability. By applying machine learning to novel data created by on-chip UCT Agents™, proteanTecs provides meaningful insights and visibility unattainable until today, leading to new levels of quality, reliability and scale. Founded in 2017, the company is headquartered in Israel with offices in New Jersey, California and Taiwan. For more information, visit: www.proteanTecs.com.

Press Contact

Tamar Naishlos, Media Relations  

tamarn@proteanTecs.com

 

Related Links :

http://www.proteantecs.com/

PR Newswire

Colombian Government selects Vitalpass, Co-created by Auna Ideas and Built on Algorand Blockchain, as the Nation’s Official Digital Vaccination Passport

Leave a comment

– This blockchain-based certificate is free and secure, as it leverages a technological process highly reliable for user data accuracy and privacy.

– Vitalpass will record and certify the vaccination status of Colombian citizens and connect with other vaccination passports globally.

BOGOTA, Colombia, Sept. 11, 2021 — Vitalpass, the COVID-19 digital vaccination passport co-created by Auna Ideas Foundation and Koibanx and developed leveraging Algorand’s blockchain, has been chosen by the Colombian government as its official immunization certificate. Colombia is the first country in Latin America to adopt this technology, joining the ranks of others already doing this, including Singapore, Japan, South Korea and New York City .

This initiative has been made possible thanks to Auna’s commitment to vaccination in Colombia and Peru, and through partnerships with local and national governments. A milestone in Colombia and Latin America, Vitalpass has been co-designed by the Innovation and HealthTech division of Auna Ideas as part of their commitment to provide comprehensive health solutions. This digital vaccination passport is free and cannot be falsified, since it creates a permanent and inalterable record on Algorand Blockchain, which is a public, decentralized network that was purpose-built for global applications that can scale to mass adoption.

Vitalpass was developed with the technological support of Koibanx, a LATAM company with more than 6 years of experience implementing blockchain-based asset tokenization and transactional solutions for the financial and government sectors.

"The use of blockchain technology makes this digital passport one of the safest and most reliable tools to guarantee the transparent process of vaccination in Colombia, because the information cannot be changed, erased or manipulated, thus ensuring the validity of the certificate against cases of forgery, double vaccination, or others," said Dr. Andrés Vásquez, Director of Biomedical Innovation and Health-Tech at Auna Ideas.

Auna Ideas Foundation has granted the Ministry of Health and Social Protection of Colombia free and perpetual rights to deploy VitalPass as the country’s tool to certify its citizens’ COVID-19 vaccination before any national or international agency. Similar agreements are expected to be signed with other governments in Latin America.

Vitalpass is part of the Commontrust Network, where multiple organizations worldwide joined efforts to give patients digital access to their health data using open, interoperable and verifiable standards. In addition, negotiations are underway to connect with GreenPass, the European Union’s COVID-19 digital immunization certification system.

With this initiative, Auna, through the Auna Ideas Foundation, reaffirms its commitment to fight COVID-19 and to leverage innovation to transform the healthcare experience of an increasing number of families in Latin America.

Auna Ideas Foundation
Auna Ideas is an open platform for scientific research, innovation in Health-Tech, health training, and social development in our continent with the support of AUNA. Since 2008 Auna seeks to transform health care and wellness in Latin America. With a presence in Peru and Colombia with more than 7,500 collaborators, they offer comprehensive health care to members and patients at every moment of their lives. They have a network of clinics and wellness centers, transversal health services, insurance products; all of this, with the support of the most advanced medical and academic research and a first-class team.

ABOUT KOIBANX
Since 2015 Koibanx has helped banks and financial institutions integrate crypto into their banking cores while connecting financial products through Blockchain infrastructure. Payments, factoring, and the tokenization of a variety of financial assets can be executed more efficiently and securely on the Koibanx platform. The company seeks to connect the LATAM financial industry over a shared infrastructure for the benefit of all players.  For more information, visit https://www.koibanx.com.

ABOUT ALGORAND
Algorand is building the technology to power the Future of Finance (FutureFi), the convergence of traditional and decentralized models into a unified system that is inclusive, frictionless, and secure. Founded by Turing Award-winning cryptographerSilvio Micali, Algorand developed a blockchain infrastructure that offers the interoperability and capacity to handle the volume of transactions needed for defi, financial institutions and governments to smoothly transition into FutureFi. The technology of choice for more than 700 global organizations, Algorand is enabling the simple creation of next generation financial products, protocols and exchange of value. For more information, visit www.algorand.com.

Algorand, Inc.
algorand@dittopr.com

 

Related Links :

http://www.algorand.com

PR Newswire

Medigate and CrowdStrike to Provide Healthcare Organizations with Unified Endpoint Security for Medical IoT Devices

Leave a comment

Integration enables comprehensive visibility, enhanced risk management and security enforcement

BROOKLYN, N.Y., Sept. 9, 2021 — Medigate, healthcare’s Best in KLAS IoT Security Provider, today announced it has partnered with CrowdStrike, a leading provider of cloud-delivered endpoint and workload protection, to provide healthcare delivery organizations (HDOs) with the industry’s first consolidated view of threat activity and incident response capability spanning all connected assets.

With the number of medical devices connecting to a hospital’s network increasing on a daily basis, HDOs struggle to maintain visibility of the location and activity of each endpoint that a device may connect to, as well as protect and manage them. Medigate and CrowdStrike solve this challenge by streamlining security responses and improving overall network efficiency.

The CrowdStrike Falcon® platform integrates with the Medigate platform allowing HDOs to perform comprehensive risk management, anomaly detection and enhanced response. The integration provides hospitals with comprehensive visibility into all managed and unmanaged devices along with enhanced threat detection capabilities that power accurate responses.

"We’ve seen a significant number of cyber and ransomware attacks against hospitals in the past year and it will only continue to rise in the future. A hospital’s focus needs to be on patient care, rather than responding to outside threats," said Matthew Polly, vice president of Worldwide Alliances, Channels and Business Development. "Medigate’s unique focus on the healthcare IoT industry is highly effective in helping to reduce attack surfaces. With CrowdStrike and Medigate, HDOs can accurately see, detect, respond and prevent attacks across the IT and clinical landscape to keep their operations and their data – including the patient information – safe."

"Today’s HDOs face specific challenges that need specialized solutions, not only in securing their vital personnel and devices, but in creating processes that ensure the benefits of connected health. By partnering with CrowdStrike, we are delivering on this vision by empowering HDOs to detect and shut-down attacks," said Jonathan Langer, chief executive officer of Medigate. "The endpoint protections our joint solution enables positions HDOs for the safe adoption of telehealth, remote patient monitoring and other networked care initiatives."

Todd Felker, former Director of Information Security at Torrance Memorial Medical Center: "As care delivery continues to fragment, the need for a centrally managed, integrated approach to securing both clinical and non-clinical endpoints is obvious. That’s why the Medigate/CrowdStrike partnership makes so much sense. I’m sure my enthusiasm for the benefits of this partnership are shared across the industry."

For more details on the Medigate and CrowdStrike partnership, check out the "Endpoint Security for Clinical Networks" solution brief.

About Medigate
Connected devices bring complicated risks, so Medigate created a simple platform to orchestrate and augment HDO security. Medigate gives the confidence to see, secure, and manage all the devices connected to the enterprise network and turn the associated data into a powerful resource for asset management and operational efficiency. It means the end of any compromise between security and usability – put simply, it allows HDOs to connect with confidence.

Logo – https://techent.tv/wp-content/uploads/2021/09/medigate-and-crowdstrike-to-provide-healthcare-organizations-with-unified-endpoint-security-for-medical-iot-devices.jpg

PR Newswire

PolyU’s research finds contact tracing is an effective way for controlling the spread of COVID-19 when borders reopen

Leave a comment

HONG KONG, Sept. 1, 2021 — As some countries in the world begin to consider adjusting their pandemic control strategy from "zero COVID" to "living with COVID", a research study by the Department of Land Surveying and Geo-Informatics at The Hong Kong Polytechnic University (PolyU) has found that contact tracing is as vital as social distancing measures and vaccination in controlling the spread of COVID-19 when borders reopen. The research team has also developed a mobile app with a contact tracing feature, designed for use by inbound travellers, that would help fight the pandemic in this respect.

The pandemic situation in Hong Kong is presently under good control, thanks to the implementation of various measures, such as social distancing and vaccination, with strong support from the general public. In the past 14 days (17-30 August), only one local case with unknown sources was reported. 

Nevertheless, the economy is facing severe challenges as the economic activity of many industries has been seriously affected as passenger traffic, in terms of both arrivals and departures, remains low.

With COVID-19 vaccinations being widely implemented in many countries, against the backdrop of needing to revive cross-border activities, there is a growing prospect of easing social distancing regulations and reopening borders in different countries and regions. As a more sustainable control strategy for the long term, focus is shifting towards living with the virus.

Professor CHEN Wu, Head and Professor of the Department of Land Surveying and Geo-Informatics at PolyU, said, "We have conducted a study that employed a computational approach to investigate the contact tracing integrated policy in different border-reopening scenarios in Hong Kong. Built on an epidemic model with 50% vaccination coverage, the results suggest that scenarios with digital contact tracing can reduce the infectious population by 84.7% compared to those without contact tracing."

One of the key recommendations drawn from the study is that contact tracing is an effective measure for reducing local virus spread, especially when it is applied along with social distancing and vaccination measures. "Contact tracing is an influential factor in controlling the spread because all the necessary pandemic control measures would not be promptly carried out without effective tracing against confirmed cases and identifying their close contacts," Professor Chen explained.

Consequently, the research team has developed a mobile app with a contact tracing feature, targeting inbound travellers when borders reopen. Utilising the Global Navigation Satellite System, Bluetooth Low Energy and Data Analysis Technology, the mobile app is designed not only for users to record individual locations they have visited but more importantly to help users identify whether they have had close contact with those who have tested positive for COVID-19 within the last 14 days.

If any user is confirmed positive for COVID-19, they can share their record with all other users at their own discretion (or through a public health department that is acting as a central coordinator on the use of the mobile app). The app on other users’ handsets will then automatically compare the individual users’ record against the record received. If the record overlaps with that of the confirmed case, individual users will be immediately alerted to take appropriate actions.

All the information recorded by the mobile app is saved in the users’ own handsets only. No personal data is required when users download or use the app, and only anonymous data will be shared with other users. The app will also provide convenience for users to access the COVID-19 pandemic information released by the Government.

Professor Chen remarked, "Contact tracing is key to effectively controlling the spread of the virus when borders reopen and the mobile app we designed for use by inbound travellers would serve as a possible solution. Furthermore, the app can be adapted for incorporating into other apps as an add-on feature."   

Media Contact

Mr Kenrick Ko

Communications and Public Affairs Office

The Hong Kong Polytechnic University

Tel: (852) 2766 6374 / 6393 1317

Email: kenrick.ko@polyu.edu.hk